Press release
Migraine Nasal Spray Market Size, Share and Trends Analysis Report 2023-2031
According to the latest research by InsightAce Analytic, the Global Migraine Nasal Spray Market is valued at USD 478.79 Mn in 2022, and it is expected to reach USD 850.09 Mn by 2031, with a CAGR of 6.8% during the forecast period of 2023-2031.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/2060
Migraine nasal sprays may be sprayed into either the nose or the two, depending on the label. Instead of taking a pill, you can quickly and effectively use a nasal spray for your migraines. In as little as 15 minutes after application, nasal sprays can begin relieving the symptoms of an acute migraine episode. Migraine nasal sprays are sprayed straight into the nostrils. The global demand for nasal sprays to treat persistent headaches, such as migraines, has risen more rapidly in recent years. The ageing population and the rise of the sedentary lifestyle drive demand in this industry.
Demand is increasing as a result of factors such as rising awareness and acceptance of therapeutic management mechanisms, improved treatment options, and the pursuit of efficiency and accuracy. Market expansion can be attributed in part to the FDA's green light for the nasal spray treatment of migraines. Rising levels of knowledge on the part of the general public have also played a crucial role in propelling the market forward. However, the expansion of the intranasal migraine drug market may be hampered by the fact that consumers may not be aware of other options for treating lung contaminations.
List of Prominent Players in the Migraine Nasal Spray Market:
• Impel NeuroPharma
• Reddy's Laboratories
• Aegis Therapeutics LLC
• Cipla
• Pfizer Inc.
• Lockhart ltd
• Tonix Pharmaceuticals
• AstraZeneca
• Upsher-Smith Laboratories
• AdvaCare Pharma
• Roche
• Dickinson and Company
• Sanofi
• Novartis AG
• Merck
• Baxter International Inc.
• Becton, Dickinson and Company
• GlaxoSmithKline
• Altius pharmaceuticals
Market Dynamics:
Drivers-
The growing demand for migraine nasal sprays is fueled by the immediate alleviation of pain, which is a major factor driving the Nasal Spray for Migraine market. Since the medicine is taken straight into the bloodstream, it avoids first-pass metabolism in the digestive system and the liver. As a result, there is now significantly more of the medication available to treat migraines. As the prevalence of chronic sinusitis has grown over the past few years, so has the potential growth of the nasal spray market for migraine headache relief.
As healthcare technology advances, we can anticipate a greater demand for nasal drugs. Migraine drugs are in high need around the world because more individuals are learning about the condition and its remedies. An additional benefit to using nasal sprays for migraine and nausea relief is that you don't have to swallow the medication.
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2060
Challenges:
The prime challenge is the lack of familiarity with other methods, strict regulations, and drug adverse consequences markets because of lockdowns and isolation in emerging countries, which is predicted to slow the growth of the migraine nasal spray market. However, anti-Headache Nasal Spray Several adverse circumstances severely restrict market expansion. Drug side effects can be debilitating and reduce demand. These include chest pain, dizziness, fatigue, and irregular pulse. Companies making intranasal migraine drugs may face difficulty if consumers aren't made aware of available options for treating lung contaminations.
Regional Trends:
The North American migraine nasal spray market is anticipated to register a major market share in revenue. It is projected to grow at a high CAGR in the near future due to migraine nasal sprays being produced in the area, and the industry invests much in R&D to boost the effectiveness of pharmacies. Increased pharmacy sector innovation and public mental health awareness have led to rising demand for migraine nasal sprays in North America.
Besides, Europe had a substantial market share because of a rise in both product availability and consumer interest, so nasal sprays have become increasingly popular. Moreover, the presence of significant market players and the growing cooperation between major players for market penetration in the area enables an opportunity to grow the global migraine nasal spray market.
Recent Developments:
• In March 2023, Pfizer Inc. made an announcement on the approval of ZAVZPRET™ (zavegepant) by the U.S. Food and Drug Administration (FDA). This nasal spray is the initial and sole calcitonin gene-related peptide (CGRP) receptor antagonist to be licenced for the immediate management of migraine in adults, whether accompanied by aura or not.
• In March 2021, The USFDA granted approval to Cipla's latest pharmaceutical product, Sumatriptan Nasal Spray, designed specifically for the treatment of migraines. The recently authorised medicine is a generic therapeutic equivalent iteration of GlaxoSmithKline's Imitrex Nasal Spray.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/2060
Segmentation of Migraine Nasal Spray Market-
By Type of Chemical -
• Nasal Triptans
• Dihydroergotamine (DHE)
• Non-steroidal anti-inflammatory drugs (NSAIDs)
By Dosage -
• 5 mg
• 10 mg
• 20 mg
• 40 mg
By Indication -
• Common Migraine
• Classic Migraine
• Cluster Migraine
• Others
By Distribution Channel-
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
For More Information: https://www.insightaceanalytic.com/report/migraine-nasal-spray-market/2060
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Site Visit: www.insightaceanalytic.com
Email: info@insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Nasal Spray Market Size, Share and Trends Analysis Report 2023-2031 here
News-ID: 3272963 • Views: …
More Releases from Insightace analytic
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"
The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%…
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031
"Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by…
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals…
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031"
The Global Data Center Liquid Cooling Market is estimated…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
